
    
      PROTOCOL OUTLINE: This is a randomized, double blind, crossover study. Patients are
      stratified according to age (3 months to 2 years vs over 2 to 18 years).

      All patients receive at least 12 months of sodium dichloroacetate (DCA) during a 2 year
      period of double blind, crossover evaluation of DCA and placebo by mouth.

      Quality of life is assessed before treatment and periodically during treatment.

      Completion date provided represents the completion date of the grant per OOPD records
    
  